Navigation Links
Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
Date:1/8/2009

BETHESDA, Md., Jan. 8 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBS and NWBT) (the "Company" or "NWBT") announced today settlement of a putative securities class action lawsuit, In re Northwest Biotherapeutics, Inc. Securities Litigation, No. C-07-1254-RAJ. The Company has agreed to pay in settlement US$1 million, which is to be funded out of insurance proceeds. The settlement must be approved by the Court. Additional details about the settlement can be found in the formal settlement documents, which are available from the United States District Court for the Western District of Washington. The case alleged that the Company misrepresented certain facts that resulted in the artificial inflation of the price of Northwest Biotherapeutics publicly-traded common stock between April 17, 2007 and July 18, 2007. The Company disputes the allegations of the lawsuit, and denies that there was any such misrepresentation or that the shares of Northwest Biotherapeutics common stock were artificially inflated. Nevertheless the Company is settling the lawsuit to avoid potentially expensive and protracted litigation.

The Company also announced today that the formal investigation by the SEC into these matters has been closed without any action taken.

Dr. Alton Boynton, CEO of Northwest Biotherapeutics, stated that, "We are pleased to have settled this litigation, and we believe this outcome is in the best interests of the Company and its shareholders. Of course, we are also pleased to have the SEC investigation behind us."

The Company will need to raise additional capital to fund its clinical trials and other operating activities and to repay indebtedness in due course. Shareholders should be aware that if the Company's capital raising efforts are unsuccessful, this will have a material adverse effect on the Company's financial position and operations.
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
2. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
3. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
4. Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
5. Northwest Secures US$4.0 Million in Debt Financing
6. Nikon Instruments Opens New Imaging Center at Northwestern University
7. Northwestern chemist investigates lost reds in Homer painting
8. Northwest Biotherapeutics to Present at Next Generation Vaccine Conference
9. Northwestern chemists take gold, mass-produce Beijing Olympic logo
10. Northwest Secures US$1.0 Million Debt Financing
11. Northwest Secures US$1.65 Million Debt Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...lif., Nov. 6 Intarcia Therapeutics...CA 650 (DUROS® continuous delivery of exenati...t the Ninth Annual Diabetes Technology Meeting in ...m.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, ...ITCA 650 Lowers Plasma Glucose, HbA1c and Reduces ...
(Date:11/5/2009)...ON -- Gone hybrid . . . , Fuel economy ratings...osted at the www.fueleconomy.gov web site, which...ains for the U.S. Department of Energy and the U.S... 10 vehicles on the best fuel economy list are hyb...y; 48 highway). "This list proves that hybrids hav...
(Date:11/5/2009)... Colo., Nov. 5 The endangered blac...western U.S. This rare carnivore feeds on prairie...plague and often entire population die-offs in tow...WS) has implemented a ferret breeding program and ...heir formerly native habitat. Unfortunately, plag...
(Date:11/5/2009)...Nov. 5 Imagenetix, Inc. ...illiam Spencer, President and CEO of Imagenetix, w...nnual LD MICRO Conference on Thursday, December 3r...es. ,, About LD MICRO ,, LD MICRO is a by-in...ing undervalued companies in the micro-cap space. ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...are flexibility , Detect Released Oligosacchari... System , Angela R. Downs Deborah A. Greer Sta...iversity, Dover, DE , We compared the Eagle Eye ... SE2000 gel imager system,for imaging Fluorophor...s. The,data generated from either system were no...
...h integrated DNA-removal step , Karen Dolter...otal RNA miniprep kit efficiently,isolates high-...,cells or 10 to 40 mg of tissue and includes an on... samples can be processed simultaneously because o...n is performed within microspin cups,which elim...
...kits target specific mutations using molecular bea...Lingyu Chen Haoqiang,Huang Jason Zhang ,Stra...ation, molecular beacons ,can distinguish human... only a,single nucleotide. We developed three si...technology, to quickly detect three common human g...
Other Biology Technology:Detect Released Oligosaccharides Using the Eagle Eye II,Still Video Imaging System 2Detect Released Oligosaccharides Using the Eagle Eye II,Still Video Imaging System 3Detect Released Oligosaccharides Using the Eagle Eye II,Still Video Imaging System 4Simple Isolation of RNA from Tissue and Cultured Cells 2Simple Isolation of RNA from Tissue and Cultured Cells 3Simple Isolation of RNA from Tissue and Cultured Cells 4Simple Isolation of RNA from Tissue and Cultured Cells 5Simple Isolation of RNA from Tissue and Cultured Cells 6Simple Isolation of RNA from Tissue and Cultured Cells 7Simple Isolation of RNA from Tissue and Cultured Cells 8Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations 2Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations 3Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations 4Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations 5Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations 6
(Date:11/9/2009)...e for the rapid, mysterious death of phytoplankton...laborating scientists at Rutgers University and th...is same chemical may hold unexpected promise in ca...y unknown lipid, or fatty compound, in a virus tha...i , a phytoplankton that plays a major role in the...
(Date:11/9/2009)... A nutritionist whose research was instrumental i...n, Infants and Children (WIC) food subsidy will re...utstanding achievement in the field of maternal-fe...a professor in the Department of Community Health ...les School of Public Health, will receive the awar...
(Date:11/8/2009)...e loss of a gene through deletion of genetic mater...t abnormalities in learning and behavior, said a c...Medicine ( www.bcm.edu ) in a report that appears ... "This research goes about 95 percent of the way t...dividuals to this gene," said Dr. Arthur L. Beaude...
Breaking Biology News(10 mins):Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Developmental delay could stem from nicotinic receptor deletion 2Highmark Caring Place To Honor Midstate Volunteers 48566 1Highmark Caring Place To Honor Midstate Volunteers 48566 2Highmark Caring Place To Honor Midstate Volunteers 48566 3New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 1New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 2New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 3New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 5New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 6PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 1PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 2PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 3PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 4PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 5
...ute of Virology and Immunology (GIVI) have identif...), a protein that acts against HIV, a finding that...fection. , The work is published today, Oct. 2, ...iences, USA. , The research, conducted by scient...Greene, MD, PhD, explains why CD4 T cells ?the imm...
...roke, paramedics, doctors, and nurses follow stand...heir efforts improve your odds for a full recovery...ction known as sepsis, which can be fatal within a...too late. , Now, a new, multicenter research cons...Shock (ProCESS), is beginning a large-scale study ...
...stem controls HIV during the earliest phases of in...sions of key immune-system molecules called HLA Cl...fragments of viral protein those molecules display...d cells. In a report in the November issue of PLO...earch Center at Massachusetts General Hospital (PA...
Other Biology News:Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G 2New study aims to stop sepsis in its tracks 2New study aims to stop sepsis in its tracks 3Early-stage immune system control of HIV may depend on inherited factors 2Early-stage immune system control of HIV may depend on inherited factors 3
HeLa Cell Slide from ProSci, Inc
EL4 Cell Slide from ProSci, Inc
IHC Select TE Buffer pH 9.0 [Antigen/ Epitope Retrieval Reagent], 10x from CHEMICON
Hep G2 Cell Slide from ProSci, Inc
Biology Products: